Skip to main content

An End-to-End Data-Driven Patient Journey: From Patient-Friendly DCT Conduct to Individualized Patient Data Return

CONFERENCE PRESENTATION · SCDM 2024 EMEA Leadership Forum & Conference
An End-to-End Data-Driven Patient Journey: From Patient-Friendly DCT Conduct to Individualized Patient Data Return
  • Session Type: Panel Discussion
  • Topics: Clinical Data Competencies & Cross-Functional Interactions, Clinical Trial Operations
  • Session Level: Intermediate
Overview
Historically, Clinical Data Management professionals have not always been sensitive enough to the voice of sites and patients. As we decentralize clinical trial activities, we need a broader perspective on the need of all drug development contributors. Join us to listen to the voice of Sites & Patients and explore what it means to the related processes and data flows.
What You'll Learn
  • Understand the difference between “Patient Centric” and “Patient Driven” approaches.
  • Dive into one of the core driver (i.e., DCT) driving our evolution to Clinical data Science.
  • Interact with Industry leaders to get your burning questions answered!

Meet the Presenters
Patrick Nadolny
Global Head, CDM
Sanofi
Patrick Nadolny has over 30 years of industry experience across pharmaceutical, device and biologics as well as technology development. He is a pragmatic leader focusing on technology, innovation, strategic planning, change management, and the setup of new capabilities. In addition to his SCDM Chair role, he leads the SCDM innovation committee, which recently released 3 reflection papers on the evolution of Clinical Data Management toward Clinical Data Science.
Agnieszka Gackowska
VP, Clinical Operations & Country Head Poland
VELOCITY CLINICAL RESEARCH
Dr Agnieszka Gackowska graduated from the Medical University of Warsaw with a diploma of Doctor of Medicine and has over 26 years of experience in the pharmaceutical industry.
Since January 2024 she has been associated with the largest research site network, Velocvity, where she is responsible for clinical operations at sites in Poland and growth and development of the company. Before she joined Velocity she led the Global Site Solutions Team at Parexel. CRO with the mission of partnering with research institutions at a strategic level to make clinical trials accessible to every patient and easier to manage for investigative teams.
In addition to this role, she also led Parexel Clinical Feasibility and Site Intelligence Teams.
Before joining Parexel, Dr Gackowska served as the Head of the Patient & Site Networks Department in CEE & ME for IQVIA and worked in big pharmaceutical companies, such as GSK and Novo Nordisk on various managing positions in the Marketing and Sales departments.
In addition to her regular job, Dr Gackowska collected her expertise as a non-profit Managing Director of the Hemophilia Foundation in Poland.
Throughout her career, she has been involved in the development of educational programs in the field of preventive medicine, vaccines, modern treatments and clinical trials, both for the medical community (doctors and nurses) and patients. She was also the creator of the program and a lecturer at postgraduate studies in the field of clinical trials conducted by the Medical University of Gdańsk, the Medical University of Lublin and the John Paul II Catholic University in Lublin.
Currently, she actively cooperates as a member with the following societies: SCRS, GCSA IAOCR and GCP.pl
Swapna Pothula
Associate Director - Data Strategy & Management
GSK
Swapna is a clinical data management professional with a deep understanding of the regulatory requirements and industry standards that govern clinical data management. Over the past 12 years, has held multiple roles within data management and worked on a wide range of clinical trials (Phase I to IV) with diversified parties such as CROs, pharmaceuticals, and biotech. Passionate about initiatives that lead to improved trust & acceleration of clinical research and is enthusiastic about applying her skills, knowledge and expertise towards the ultimate purpose of getting ahead of disease & transforming patients’ lives.
Earn CEUs
SCDM is authorized by IACET to offer 0.2 CEUs for this education program. Participants are eligible to receive CEUs upon successful completion of the digital assessment questionnaire linked to this session, within 30 days after the purchase of the conference session.

Price
SCDM members: $50
Non-members: $175

Not yet an SCDM member? Purchase this conference session and get a one-year membership with SCDM on us to enjoy all our educational programs and sessions at a discounted price.
Need support?
Technical support:
Click on the help button on the bottom right, select contact support and email the BlueSky team with any technical issues. Otherwise e-mail directly to support@blueskyelearn.com or call +1-888-705-6002 for immediate help.

General support:
The SCDM Learning team is here to help. Contact us at learning@scdm.org or call +32 232 024 87.